webinar register page

Alzheimer Awareness month Public Lecture: Aducanumab and Research Update
Join us to hear Dr. Sharon Cohen, Medical Director and Principal Investigator at Toronto Memory Program as she discusses the exciting news of the FDA’s approval of the use of aducanumab. It is the first new treatment for Alzheimer's disease in 20 years and the very first disease-modifying drug proven to slow AD progression.

Jan 26, 2022 07:00 PM in Eastern Time (US and Canada)

* Required information
Loading